medRxiv·1 SepReturning APOE and pTau-217 Results: the eSMARTER Randomized Noninferiority Clinical TrialPreprint: trial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecExploring Characteristics Predictive of Willingness to Participate in Preclinical Alzheimer’s Disease TrialsStudy in peoplePopulationsPaper
AAIC 2025 Abstract·25 DecAssessing the Utility of Recruitment Strategies for Preclinical Alzheimer’s Disease Trials Among Racial and Ethnic GroupsStudy in peoplePopulationsPaper
AAIC 2025 Abstract·25 DecEvaluation of Self‐Mediated Alternatives for Risk Testing Education and Return of Results ‐ eSMARTER: A randomized trial from the Alzheimer’s Prevention Initiative programTrial in peopleInterventionsPaper
AAIC 2025 Abstract·25 DecReturning pTau‐217 results: Methods from the Evaluation of Self‐Mediated Alternatives for Risk Testing Education and Return of Results (eSMARTER) studyTrial in peopleInterventionsPaper
AAIC 2025 Abstract·23 DecNativity differences in willingness to participate in preclinical AD trialsStudy in peoplePopulationsPaper